Article
Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2
27 Apr 2022
Abstract excerpt
Currently, SARS-CoV-2, especially the Omicron strain, is ravaging the world and even co-infecting human beings with IAV, which is a serious threat to human public health. As of yet, no specific antiviral drug has been discovered for SARS-CoV-2. This requires deeper understandings of the molecular mechanisms of SARS-CoV-2-host interaction, to explore antiviral drug targets and provide theoretical basis for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
